Featured Stories World News Commentary Money Watch Multimedia Prison Planet U.S. News Science And Technology

Pharmaceutical companies write their own drug information labels and leave out side effect information

  • Print The Alex Jones Channel Alex Jones Show podcast Prison Planet TV Infowars.com Twitter Alex Jones' Facebook Infowars store

Natural News
Tuesday, Nov 24th, 2009

Two doctors from the Dartmouth Institute for Health Policy and Clinical Practice recently reported that many prescription drug labels do not contain accurate information about all side effects and the true severity of listed side effects, and they fail to mention that certain medicines are not truly effective.

A long standing problem, drug companies are in charge of writing their own drug information which is then presented to the Food and Drug Administration (FDA) for final approval. Though tasked with negotiating accurate and sensible wording, the FDA often lets slide inadequate information that is both misleading and outright deceptive.

Lunesta, a prescription sleeping drug created by Sepracor Inc., is touted on its information label as being superior to placebo in alleviating insomnia and inducing restful sleep. Test results from the most comprehensive study performed on the drug revealed that the drug did not reduce insomnia and that there were no meaningful improvements in next-day functioning and alertness as drug advertisements claimed.

Even though the study’s findings were provided to the FDA for further review, the FDA allowed misleading information to be published on Lunesta’s information sheet anyway. In response to allegations that the company is misleading the public about Lunesta, Sepracor retorted that information above and beyond what is required by the FDA is always available to those who request it.

Pharmaceutical companies write their own drug information labels and leave out side effect information  071009banner3

Rozerem, another insomnia drug produced by Takeda Pharmaceutical Co., omitted similar information from its drug information sheet. Though no empirical sleeping improvements occurred in test patients who received treatment with Rozerem, the company did not disclose this fact on the product label. Takeda continues to market the product untruthfully.

Other examples of drug label deception include Novartis’ Zometa bone cancer drug. The drug’s information label states that ingesting the 8-milligram dose poses a greater risk of kidney damage with no explanation about how great a risk. Truth be told, 33 percent of patients in a test study died when taking the 8-milligram dose of Zometa.

  • A d v e r t i s e m e n t

As disturbing as all of this is, it illustrates the grave failure of the FDA in performing its job. Drug companies seemingly run the show from start to finish, researching, manufacturing, and self-regulating their own products. The FDA time and time again has caved at the behest of corporate pressure.

The FDA must be held responsible for its utter failure to function as it should. In direct opposition to its own mission statement which summates its purpose as defender of public health, the FDA operates as a corporate lapdog to pharmaceutical interests. It is time that the people demand the dismantling of this corrupt organization and the formation of a new one.

“When the people find they can vote themselves money, that will herald the end of the republic.”Fall Of The RepublicBuy the DVD here

Pharmaceutical companies write their own drug information labels and leave out side effect information  FOTR 340x1692 

This article was posted: Tuesday, November 24, 2009 at 5:03 am





Infowars.com Videos:

Comment on this article

Comments are closed.

Watch the News

FEATURED VIDEOS
The Truth About U.S. Air Strikes on Syria With Syrian Girl See the rest on the Alex Jones YouTube channel.

Mysterious Georgia Guidestones Get Strange '2014' Update See the rest on the Alex Jones YouTube channel.

© 2013 PrisonPlanet.com is a Free Speech Systems, LLC company. All rights reserved. Digital Millennium Copyright Act Notice.